Trial Profile
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2023
Price :
$35
*
At a glance
- Drugs Brexanolone (Primary)
- Indications Alcoholism; Post-traumatic stress disorders
- Focus Adverse reactions; Proof of concept
- 12 Oct 2023 Planned End Date changed from 1 Oct 2023 to 30 Apr 2024.
- 12 Oct 2023 Planned primary completion date changed from 1 Oct 2023 to 30 Apr 2024.
- 12 Oct 2023 Status changed from not yet recruiting to recruiting.